Lei Deng, MD
University of Washington/Fred Hutch Cancer Center
Conference Co-Chair
Biography
Dr. Lei Deng is an assistant professor within the Thoracic, Head & Neck medical oncology group, at University of Washington and Fred Hutchinson Cancer Center. He is interested in clinical and translational thoracic cancer research focusing on novel biomarkers and therapeutics, particularly MTAP and KRAS-altered lung cancer. He is also interested in optimizing systemic therapy for patients undergoing curative surgery and definitive radiotherapy. Dr. Deng co-leads the early-career working group at IASLC's Career Development Committee. He organized and chaired the first IASLC Grant Workshop at the annual World Conference on Lung Cancer since 2024.
Financial Disclosure
Bristol Myers Squibb, Regeneron, Boehringer Ingelheim
Consultant
BridgeBio Oncology Therapeutics, Merck, Solve Therapeutics, Bristol Myers Squibb, BillionToOne, Revolution Medicines, Daiichi Sankyo
Grant Or Contract
MJH Life Science, PrecisCa, DAVA Oncology, Curio Science, CardinalHealth, IDEOlogy Health, Curta, Binaytara Foundation, Total Health
Professional Service